YANYAN LIU

Affiliation and department：

Research field (1)： Metabolism and endocrinology

Research theme for competitive and other funds (1)：

Papers (14)：

Megumi Yasuda, Katsumi Iizuka, Takehiro Kato, Yanyan Liu, Ken Takao, Kenta Nonomura, Masami Mizuno, Daisuke Yabe. Sodium-glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report. Journal of diabetes investigation. 2020. 11. 3. 745-747
Liu Y, Kubota S, Iizuka K, Yabe D. Cardioprotective effects of GLP-1(28-36a): A degraded metabolite or GLP-1’s better half?. Journal of Diabetes Investigation. 2020. in press
Kuwabara-Ohmura Y, Iizuka K, Liu Y, Takao K, Nonomura K, Kato T, Mizuno M, Hosomichi K, Tajima A, Miyazaki T, et al. A case of MODY5-like manifestations without mutations or deletions in coding and minimal promoter regions of the HNF1B gene. Endocrine Journal. 2020. in press
Yanyan Liu, Shin-Ichi Harashima, Yu Wang, Kazuyo Suzuki, Shinsuke Tokumoto, Ryota Usui, Hisato Tatsuoka, Daisuke Tanaka, Daisuke Yabe, Norio Harada, et al. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019. 33. 5. 6239-6253
古谷太志, 藤田義人, 松尾奈緒美, 小栗靖生, 南野寛人, 王宇, 劉彦言, 池田香織, 原島伸一, 稲垣暢也. SGLT2阻害薬の肝臓における代謝動態への影響および効果発現に寄与する因子の解明. 糖尿病. 2018. 61. Suppl.1. S-230

ｍore...

MISC (8)：

劉彦言, 飯塚勝美, 矢部大介. SGLT2阻害薬の心・腎保護効果. 薬事日報. 2020. 12277. 4-4
劉彦言, 原島伸一, 王宇, 鈴木和代, 徳本信介, 臼井亮太, 龍岡久登, 田中大祐, 矢部大介, 原田範雄, et al. Sphingosine kinase 1-interacting proteinはインスリン及びインクレチン分泌の双方の制御因子である. 日本臨床分子医学会学術総会プログラム・抄録集. 2019. 56回. 69-69
Yanyan Liu, Shin-ichi Harashima, Yu Wang, Nobuya Inagaki. Sphingosine Kinase Type-1-interacting Protein (SKIP) Regulates Incretin Secretion and Fat Composition. DIABETES. 2016. 65. A502-A502
劉彦言, 原島伸一, 王宇, 稲垣暢也. Sphingosine kinase type1-interacting protein(SKIP)はインクレチン分泌を抑制する. 糖尿病(Web). 2016. 59. Suppl. S.302(J-STAGE)-302
王宇, 原島伸一, 劉彦言, 稲垣暢也. Sphingosine kinase type1-interacting protein(SKIP)はインスリン分泌を抑制する. 糖尿病(Web). 2016. 59. Suppl. S.194(J-STAGE)-194

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page